A detailed history of Liberty Wealth Management LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Liberty Wealth Management LLC holds 3,179 shares of GILD stock, worth $280,006. This represents 0.04% of its overall portfolio holdings.

Number of Shares
3,179
Holding current value
$280,006
% of portfolio
0.04%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 06, 2024

BUY
$63.15 - $72.88 $200,753 - $231,685
3,179 New
3,179 $218,000
Q4 2021

Feb 15, 2022

SELL
$64.88 - $73.64 $217,477 - $246,841
-3,352 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$67.69 - $73.03 $82,852 - $89,388
1,224 Added 57.52%
3,352 $232,000
Q2 2021

Aug 13, 2021

SELL
$63.47 - $69.35 $9.16 Million - $10 Million
-144,376 Reduced 98.55%
2,128 $147,000
Q2 2021

Aug 13, 2021

BUY
$63.47 - $69.35 $9.13 Million - $9.98 Million
143,881 Added 5485.36%
146,504 $2.13 Million
Q4 2020

Feb 09, 2021

BUY
$56.65 - $64.55 $27,815 - $31,694
491 Added 23.03%
2,623 $170,000
Q3 2020

Nov 05, 2020

BUY
$62.1 - $78.08 $74,333 - $93,461
1,197 Added 128.02%
2,132 $135,000
Q2 2020

Aug 04, 2020

SELL
$72.34 - $84.0 $31,250 - $36,288
-432 Reduced 31.6%
935 $72,000
Q1 2020

Apr 27, 2020

SELL
$62.63 - $80.22 $5,448 - $6,979
-87 Reduced 5.98%
1,367 $102,000
Q4 2019

Feb 05, 2020

BUY
$61.62 - $67.78 $431 - $474
7 Added 0.48%
1,454 $94,000
Q3 2019

Oct 30, 2019

SELL
$62.51 - $69.0 $35,005 - $38,640
-560 Reduced 27.9%
1,447 $92,000
Q2 2019

Jul 30, 2019

BUY
$61.87 - $69.38 $112,789 - $126,479
1,823 Added 990.76%
2,007 $136,000
Q1 2019

Apr 18, 2019

SELL
$62.53 - $70.05 $3,876 - $4,343
-62 Reduced 25.2%
184 $11,000
Q4 2018

Mar 26, 2019

BUY
$60.54 - $79.0 $14,892 - $19,434
246 New
246 $15,000

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $110B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Liberty Wealth Management LLC Portfolio

Follow Liberty Wealth Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Liberty Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Liberty Wealth Management LLC with notifications on news.